Esketamine nasal and Kisqali Femara Co-Pack
Determining the interaction of Esketamine nasal and Kisqali Femara Co-Pack and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esketamine nasal-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Esketamine nasal-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Esketamine nasal-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Esketamine nasal-Kitabis Pak
- Esketamine nasal-Kitabis Pak inhalation
- Esketamine nasal-Klofensaid II
- Kisqali Femara Co-Pack-Eslicarbazepine
- Kisqali Femara Co-Pack-Eslicarbazepine Acetate
- Kisqali Femara Co-Pack-Esmolol
- Kisqali Femara Co-Pack-Esmolol HCl
- Kisqali Femara Co-Pack-Esmolol Hydrochloride
- Kisqali Femara Co-Pack-Esmolol Injection